DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Slovakia
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
1BSL01AE logo

Biotika a.s. Stock Price

BSSE:1BSL01AE Community·€11.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

1BSL01AE Share Price Performance

€17.00
10.00 (142.86%)
​
€17.00
10.00 (142.86%)
​
Price €17.00
Wed, 16 Sep 26
Share Pricen/a

1BSL01AE Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards
View Full Analysis

Biotika a.s. Key Details

€18.2m

Revenue

€14.0m

Cost of Revenue

€4.1m

Gross Profit

€5.3m

Other Expenses

-€1.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.70
22.76%
-6.55%
13.5%
View Full Analysis

About 1BSL01AE

Founded
1953
Employees
165
CEO
Marek Tarda
WebsiteView website
www.biotika.sk

Biotika a.s., a biotechnology company, manufactures active pharmaceutical ingredients in Slovakia and internationally. It is involved in manufacturing Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate; contract manufacturing of Gramicidin S Hydrocholoride; import and distribution of active ingredients; production of chemical products, such as disinfectants and organic chemicals; and production of human and veterinary medicines, food products, including beverages, protein substances, and derivatives. The company also engages in research and development in the field of natural and technical sciences; production of feed additives and export to third countries; production and sale of compost and organic fertilizer; and rental of real estate and movable property. Biotika a.s. was founded in 1953 and is based in Slovenská Lupca, Slovakia.

Recent 1BSL01AE News & Updates

Analysis Article • Oct 31

Investors Still Aren't Entirely Convinced By Biotika a.s.'s (BSSE:1BSL01AE) Revenues Despite 29% Price Jump

Biotika a.s. ( BSSE:1BSL01AE ) shareholders would be excited to see that the share price has had a great month, posting...

Recent updates

No updates

Biotika a.s. Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide